Article
A Pediatric Case of Blau Syndrome with NOD2 p.Arg587Cys Mutation Successfully Managed with Infliximab: A Long-Term Follow-Up Study.
Ocular immunology and inflammation - 1 Aug 2026
Sakono Takuto, Mizuki Yuki, Takebayashi Kyouko, Ishihara Mami, Kawagoe Tatsukata, Ohno Shigeaki, Mizuki Nobuhisa
Abstract excerpt
PURPOSE: To describe the long-term ocular and systemic course of a pediatric patient with Blau syndrome carrying aNOD2p.Arg587Cys mutation, and to report the therapeutic response to infliximab after inadequate disease control with adalimumab. METHODS: Single-case report of a girl with genetically confirmed Blau syndrome managed at a tertiary referral center for pediatric uveitis in Japan. Clinical findings,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
